Elevation Oncology, Inc.
ELEV
$0.381
-$0.0039-1.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.95% | 2.67% | 26.21% | 53.32% | 58.52% |
| Total Depreciation and Amortization | -51.28% | -38.46% | -25.64% | -13.16% | 18.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.23% | 34.11% | -17.29% | -20.04% | -16.76% |
| Change in Net Operating Assets | 139.01% | 128.04% | 102.60% | 40.99% | -637.61% |
| Cash from Operations | 19.26% | 35.27% | 38.00% | 53.26% | 44.59% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -194.05% | -172.47% | -182.11% | -171.63% | -90.83% |
| Cash from Investing | -194.05% | -172.47% | -182.11% | -171.72% | -90.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.16% | -5.92% | -5.92% | -5.83% | 34,196.93% |
| Repurchase of Common Stock | -2.63% | -100.00% | -76.92% | -62.07% | 19.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 86.67% | -- | -- | 63.83% | 68.09% |
| Cash from Financing | -81.19% | -6.33% | -6.32% | -41.97% | 162.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.78% | -93.74% | -391.66% | -189.39% | 1,100.00% |